Answers are grounded in this paper and cite their sources.
Background Early differential diagnosis of active tuberculosis (TB) and latent tuberculosis infection (LTBI) is crucial for TB prevention and treatment. Both matrix metalloproteinases (MMPs) and inflammatory markers participate in TB-related inflammation, but their combined value in TB differentiation remain unclear. This study aimed to evaluate the analytical performance of the MAGLUMI MMP-1 and MMP-7 assays, and to explore the diagnostic value of MMP-1, MMP-7 combined with traditional inflammatory markers in distinguishing TB from LTBI. Study design We assessed the precision, linearity, limit of blank (LoB), limit of detection (LoD), limit of quantification (LoQ), interference and trueness of MAGLUMI MMP-1 and MMP-7 assays. We enrolled 146 subjects (39 healthy controls, 46 LTBI, 61 TB), detected their MMP-1, MMP-7 and inflammatory marker levels, and used Mann Whitney test, logistic regression and receiver operating characteristic (ROC) curve for statistical analysis. Results Both MAGLUMI MMP-1 and MMP-7 assays showed good precision, linearity and trueness. TB patients were older than LTBI subjects ( P = 0.008) with significantly higher rates of cough/sputum ( P < 0.001), chest pain ( P = 0.030) and characteristic imaging findings (cavitation, focal consolidation, reticular interstitial pattern: P < 0.001). MMP-1, CRP, SAA, IL-6, and PCT were significantly higher in TB (MMP-1: P = 0.045; others: P < 0.001) compared to LTBI, while no significant differences were found in MMP-7 and TNF-α. Among the single markers, CRP (AUC = 0.802, 95% confidence interval (CI): 0.720-0.884) had the higher diagnostic efficacy, and the combination of age, CRP, SAA, IL-6 and PCT had the highest AUC of 0.899 (95% CI: 0.841-0.956), with a sensitivity of 89% and a specificity of 80%. However, the addition of MMP-1 did not improve the discriminative ability of the combined model. Conclusions MAGLUMI MMP-1 and MMP-7 assays have reliable analytical performance. Age, CRP, SAA, IL-6, and PCT are valuable for differentiating TB from LTBI, and their combination enhances diagnostic efficacy. However, increasing MMP-1 or 7 does not improve the differential diagnostic performance of the above model, even though there are differences in MMP-1 between groups.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: